Product Information
BRIMONIDINE TARTRATE 0.15% DRP is a generic product labeled by Pacific Pharma, Inc., priced at $11.6520 per ML under NDC 82182077315. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Mar 16, 2001. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.5 mg/mL
Manufacturer
Pacific Pharma, Inc.NDC
82182077315
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021262FDA Approved
3/16/2001
TE Code
AT
On Market Since
2/28/2022
Pharmacological Classes
Price Statistics
The NADAC for BRIMONIDINE TARTRATE 0.15% DRP has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 54.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.6520 per ML |
|---|---|
| All-time high | $29.7292 (Jul 13, 2022) |
| All-time low | $10.2709 (Jun 17, 2026) |
| 52-week high | $16.1905 |
| 52-week low | $10.2709 |
| Median price | $15.8576 |
| Average price | $16.8527 |
| Largest weekly change | -27.7% (May 22, 2024) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pacific Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
brimonidine tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BRIMONIDINE TARTRATE 0.15% DRP?
The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.15% DRP, manufactured by Pacific Pharma, Inc., is $11.6520 per ML (NDC 82182077315), effective Sep 30, 2026.
How has the price of BRIMONIDINE TARTRATE 0.15% DRP changed over time?
Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.15% DRP has declined 54.7%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.15% DRP?
Since Jun 1, 2022, the NADAC for BRIMONIDINE TARTRATE 0.15% DRP has ranged from a low of $10.2709 (Jun 17, 2026) to a high of $29.7292 (Jul 13, 2022), with a median of $15.8576 per ML.
Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.15% DRP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE TARTRATE 0.15% DRP, is $9.7473 per ML — about 16% below BRIMONIDINE TARTRATE 0.15% DRP.
Who manufactures BRIMONIDINE TARTRATE 0.15% DRP?
BRIMONIDINE TARTRATE 0.15% DRP (NDC 82182077315) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.